{
  "abstract": "We read with interest the study by Dr Coleman and colleagues and think that their findings are reflective of patterns found in previous comparisons between bupivacaine and mepivacaine.1 However, we would like to take this opportunity to highlight a few reservations we have.",
  "authors": [
    {
      "affiliations": [
        "Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, Maryland, USA"
      ],
      "name": "Bradley Vost"
    },
    {
      "affiliations": [
        "Department of Orthopaedics/Population Health Science and Policy, Hospital for Special Surgery, New York, New York, USA"
      ],
      "name": "Jashvant Poeran"
    },
    {
      "affiliations": [
        "Department of Anesthesiology, Weill Cornell Medicine, New York, New York, USA"
      ],
      "name": "Michelle Carley"
    },
    {
      "affiliations": [
        "Department of Anesthesiology, Critical Care & Pain Management, Hospital for Special Surgery, New York, New York, USA"
      ],
      "name": "Daniel Maalouf"
    }
  ],
  "title": "Letter to the editor regarding ‘Transitioning from intrathecal bupivacaine to mepivacaine for same-day discharge total joint arthroplasty: a quality improvement study’",
  "uid": "23890666-d33d-5c15-9d71-27969f9af0b9"
}